Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings expectations. Reported EPS is $7.54, expectations were $6.91. Operator: Thanks ...

Eli Lilly is upgraded to Buy after a 13% pullback and strong Q4 guidance, with potential for 25% topline growth in 2026.

Eli Lilly topped Novo in terms of both revenue and net income. Moderna’s stable financials were overshadowed by the regulatory whiplash it experienced in mid-February. Similarly, the vaccine segments ...

Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) reported quarterly results in early February, and the gap between them has widened significantly. Lilly's tirzepatide franchise is ...

Jensen Investment Management, an asset management company based in the US, released its fourth-quarter investor letter for “Jensen Quality Growth Equity Strategy”. A copy of the letter can be ...

Eli Lilly is set to post earnings Thursday morning, with the stock seen potentially sinking to its lowest level in months ...

A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 people in Indianapolis and ...